1. Cohen, KA, Hopkins J, Ingraham R, Pargellis C, Wu JC, Palladino DEH, Kinkade P, Warrent TC, Rogers S, Adams J, Farina PR, Grob P (1991): Characterization of the binding site for BI-RG-587, a non-nucleoside inhibitor of HIV-1 reverse transcriptase. J Biol Chem 266:14670–14674.
2. Goldman ME, Nunberg JH, O’Brien JA, Quintero JC, Schleif WA, Freund KF, Gaul SL, Saari WS, Wai JS, Hoffman JM, Anderson PS, Hupe DJ, Emini EA, Stern AM (1991): Pyridinone derivatives: Specific human immunodeficiency virus type 1 reverse transcriptase inhibitors with antiviral activity. Proc Natl Acad Sci USA 88:6863–6867.
3. Kohlstaedt LA, Wang J, Friedman JM, Rice PA, Steitz TA (1992): Crystal structure at 3.5 A resolution of HIV-reverse transcriptase complexed with an inhibitor. Science 25:1782–1790.
4. Koup RA, Merluzzi VJ, Hargrave KD, Adams J, Grozinger K, Eckner RJ, Sullivan JL (1991): Inhibition of human immunodeficiency virus type 1 (HIV-1) replication by the dipyridodiazepinone BI-RG-587. J Infect Dis 163:966–970.
5. Merluzzi VJ, Hargrave KD, Labadia M, Grozinger K, Skoog M, Wu JC, Shih C-K, Eckner K, Hattox S, Adams J, Rosenthal AS, Faanes R, Eckner RJ, Koup RA, Sullivan JL (1990): Inhibition of HIV-1 replication by a nonnucleoside reverse transcriptase inhibitor. Science 250:1411–1413.